Legal.
Fushun Science and Technology Co., Ltd. has launched strategic cooperation with senior investment banks such as Hillhouse Capital, Sequoia Capital, and Yishang Club to enter the domestic health industry, especially the construction of hospitals and health examination centers in the central and western regions. , improve the medical level and public health in the central and western regions. Fushun Medical Innovation Co., Ltd. (hereinafter referred to as "Fushun Medical") belongs to Wanlijia Group Holdings Co., Ltd. and is located in Shenzhen. It focuses on the investment and industrialization of national biotechnology, medical care, and environmentally friendly energy, and is responsible for the creation of major national new drugs. Project units and national high-tech enterprises.
Fushun Medical is committed to becoming an innovation-driven biopharmaceutical company based on a high-end technology platform and equipped with a complete system from product research and development to industrialization. At present, the company has received funding from a number of national major new drug creation special projects during the 11th, 12th, and 13th Five-Year Plans and Shanghai scientific research projects. At the same time, Fushun Medical attaches great importance to the protection of intellectual property rights and provides patent protection for core technologies of projects under research. It is currently applying for and has been authorized 35 domestic invention patents and 30 international PCT invention patents.